TOKYO -- Japan's Ricoh will create a new fund to invest in pharmaceutical startups working with messenger RNA technology, accelerating its push to diversify beyond copiers and other office equipment.
Pharmaceuticals
Ricoh to launch $7m seed fund to back Japan's mRNA startups
Company targets fledgling businesses with eye toward boosting contract drugmaking
Ricoh entered the contract drugmaking industry by acquiring a U.S. startup in July. (Photo courtesy of Ricoh)
Read Next
Latest on Pharmaceuticals
